Total Payments
$8,783
2024 Payments
$738.78
Companies
37
Transactions
463
Medicare Patients
1,821
Medicare Billing
$208,418
Payment Breakdown by Category
Food & Beverage$8,394 (95.6%)
Education$138.92 (1.6%)
Consulting$125.00 (1.4%)
Research$125.00 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,394 | 456 | 95.6% |
| Education | $138.92 | 5 | 1.6% |
| Unspecified | $125.00 | 1 | 1.4% |
| Consulting Fee | $125.00 | 1 | 1.4% |
Payments by Type
General
$8,658
462 transactions
Research
$125.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,240 | 98 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $812.44 | 40 | $0 (2022) |
| Lilly USA, LLC | $792.36 | 35 | $0 (2024) |
| PFIZER INC. | $729.07 | 39 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $716.54 | 41 | $0 (2024) |
| Amgen Inc. | $679.15 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $483.38 | 22 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $354.24 | 14 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $353.32 | 21 | $0 (2022) |
| GlaxoSmithKline, LLC. | $347.59 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $738.78 | 36 | Amgen Inc. ($191.51) |
| 2023 | $607.19 | 23 | Lilly USA, LLC ($307.90) |
| 2022 | $764.47 | 39 | Lilly USA, LLC ($161.09) |
| 2021 | $858.02 | 47 | Novartis Pharmaceuticals Corporation ($156.57) |
| 2020 | $956.09 | 48 | Teva Pharmaceuticals USA, Inc. ($153.41) |
| 2019 | $1,842 | 76 | Janssen Pharmaceuticals, Inc ($265.50) |
| 2018 | $1,491 | 95 | Novartis Pharmaceuticals Corporation ($369.27) |
| 2017 | $1,525 | 99 | Novartis Pharmaceuticals Corporation ($333.76) |
All Payment Transactions
463 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Cardio-renal | ||||||
| 06/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Cardiology | ||||||
| 05/23/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Respiratory | ||||||
| 05/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes | ||||||
| 04/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/24/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $25.14 | General |
| 04/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.96 | General |
| Category: Cardio-renal | ||||||
| 04/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: DIABETES | ||||||
| 04/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: Inflammation | ||||||
| 04/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Inflammation | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Respiratory | ||||||
| 04/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.22 | General |
| Category: Cardiology | ||||||
| 03/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Inflammation | ||||||
| 03/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior about SUBOXONE buprenorphine and naloxone Sublingual Film CIII Safety and Use Information | Indivior Inc. | $125.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 322 | 588 | $121,888 | $47,010 |
| 2022 | 11 | 398 | 677 | $130,380 | $51,646 |
| 2021 | 19 | 515 | 935 | $121,043 | $50,807 |
| 2020 | 16 | 586 | 917 | $161,487 | $58,954 |
Total Patients
1,821
Total Services
3,117
Medicare Billing
$208,418
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 146 | $32,624 | $10,472 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 152 | $24,556 | $10,088 | 41.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 90 | $20,633 | $9,042 | 43.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 39 | $15,848 | $5,708 | 36.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 54 | 69 | $15,366 | $5,344 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 23 | 23 | $4,486 | $3,110 | 69.3% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 27 | 29 | $4,756 | $1,836 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 19 | $2,820 | $1,006 | 35.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $799.84 | $403.83 | 50.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 172 | $37,857 | $15,167 | 40.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 178 | $28,030 | $10,663 | 38.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 71 | $15,753 | $6,115 | 38.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 30 | $12,828 | $5,015 | 39.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 32 | 32 | $6,096 | $4,427 | 72.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 78 | $11,394 | $3,889 | 34.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 22 | 23 | $3,831 | $1,501 | 39.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 13 | $3,969 | $1,378 | 34.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 29 | 29 | $5,704 | $1,339 | 23.5% |
| 99358 | Extended patient service without direct patient contact, first hour | Facility | 2022 | 11 | 12 | $2,953 | $1,121 | 38.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 21 | $1,220 | $653.52 | 53.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 16 | 18 | $745.05 | $377.94 | 50.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 161 | $34,757 | $14,282 | 41.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 44 | 215 | $19,624 | $6,791 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 99 | $14,161 | $6,683 | 47.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 63 | $9,719 | $3,819 | 39.3% |
About Dr. Ananta Pandit, M.D
Dr. Ananta Pandit, M.D is a Adolescent Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1073826327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ananta Pandit, M.D has received a total of $8,783 in payments from pharmaceutical and medical device companies, with $738.78 received in 2024. These payments were reported across 463 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,394).
As a Medicare-enrolled provider, Pandit has provided services to 1,821 Medicare beneficiaries, totaling 3,117 services with total Medicare billing of $208,418. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Adolescent Medicine
- Other Specialties Internal Medicine
- Location Chicago, IL
- Active Since 07/15/2010
- Last Updated 02/08/2022
- Taxonomy Code 207RA0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073826327
Products in Payments
- ENTRESTO (Drug) $1,177
- XARELTO (Drug) $611.52
- ELIQUIS (Drug) $576.45
- MOUNJARO (Drug) $517.74
- LifeVest (Device) $353.32
- SYMBICORT (Drug) $262.00
- CHANTIX (Drug) $234.23
- JARDIANCE (Drug) $223.05
- Kerendia (Drug) $216.47
- INVOKANA (Drug) $200.92
- EVENITY (Biological) $193.58
- AUSTEDO (Drug) $189.55
- Vascepa (Drug) $165.51
- TRELEGY ELLIPTA (Drug) $160.77
- Prolia (Biological) $158.70
- TOUJEO (Drug) $143.94
- SPIRIVA RESPIMAT (Drug) $125.75
- SUBOXONE (Drug) $125.00
- SUBOXONE SUBLINGUAL FILM (Drug) $125.00
- ZENPEP (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adolescent Medicine Doctors in Chicago
Ebony Copeland, M.d, M.D
Adolescent Medicine — Payments: $98,274
Adolescent Medicine $98,274
Dr. Jaime Martinez, M.d, M.D
Adolescent Medicine — Payments: $1,760
Adolescent Medicine $1,760
Cari Tarnowski, D.o, D.O
Adolescent Medicine — Payments: $1,740
Adolescent Medicine $1,740
Tram Luu, M.d, M.D
Adolescent Medicine — Payments: $1,295
Adolescent Medicine $1,295
Laura Mikhail, M.d, M.D
Adolescent Medicine — Payments: $1,248
Adolescent Medicine $1,248
Sonia Wengerhoff, M.d, M.D
Adolescent Medicine — Payments: $506.80
Adolescent Medicine $506.80